Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Common Equity (2023 - 2025)

Wellgistics Health filings provide 3 years of Common Equity readings, the most recent being -$12.4 million for Q4 2025.

  • On a quarterly basis, Common Equity fell 284.84% to -$12.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.4 million, a 284.84% decrease, with the full-year FY2025 number at -$12.4 million, down 284.84% from a year prior.
  • Common Equity hit -$12.4 million in Q4 2025 for Wellgistics Health, down from $6.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $10.0 million in Q3 2024 to a low of -$12.4 million in Q4 2025.
  • Median Common Equity over the past 3 years was $905255.0 (2025), compared with a mean of $822433.8.
  • Biggest five-year swings in Common Equity: soared 332.19% in 2024 and later crashed 284.84% in 2025.
  • Wellgistics Health's Common Equity stood at -$2.9 million in 2023, then soared by 332.19% to $6.7 million in 2024, then crashed by 284.84% to -$12.4 million in 2025.
  • The last three reported values for Common Equity were -$12.4 million (Q4 2025), $6.8 million (Q3 2025), and $905255.0 (Q2 2025) per Business Quant data.